Dr. Reddy's Laboratories Limited
RDY
Price:
$13.3
Market Cap:
$1.07T
Dr. Reddy's Laboratories Limited, alongside its associated companies, functions as a holistic pharmaceutical entity with a global footprint. Its business operations are divided into several key divisions. The Global Generics segment is responsible for the manufacturing and sale of both prescription and over-the-counter finished pharmaceutical products. These offerings are available either under a proprietary brand or as generic formulations that are therapeutically identical to their branded equivalents. This segment also includes the company's biologics ventures. The Pharmaceutical Services and Active Ingredients (PSAI) division focuses on producing and distributing active pharmaceutical in...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2001-04-11
Stock Exchange
NYSE
Ticker
RDY
PE Ratio
[24.63]
ROE
[11.76%]
Current Ratio
[1.80]
Dividend Yield
[0.62%]
Enterprise Value
[1.14T]
Dividend History
The ROE as of June 2026 (TTM) for Dr. Reddy's Laboratories Limited (RDY) is 11.76%
According to Dr. Reddy's Laboratories Limited’s latest financial reports and current stock price. The company's current ROE is 11.76%. This represents a change of 295.42% compared to the average of 2.97% of the last 4 quarters.
Dr. Reddy's Laboratories Limited (RDY) Historical ROE (quarterly & annually)
How has RDY ROE performed in the past?
The mean historical ROE of Dr. Reddy's Laboratories Limited over the last ten years is 13.35%. The current 11.76% ROE has changed -11.92% with respect to the historical average. Over the past ten years (40 quarters), RDY's ROE was at its highest in in the September 2019 quarter at 7.10%. The ROE was at its lowest in in the December 2019 quarter at -3.83%.
Average
13.35%
Median
12.48%
Minimum
7.75%
Maximum
19.85%
Dr. Reddy's Laboratories Limited (RDY) ROE by Quarter and Year
Discovering the peaks and valleys of Dr. Reddy's Laboratories Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 72.89%
Maximum Annual ROE = 19.85%
Minimum Annual Increase = -37.76%
Minimum Annual ROE = 7.75%
| Year | ROE | Change |
|---|---|---|
| 2026 | 11.36% | -33.00% |
| 2025 | 16.96% | -14.55% |
| 2024 | 19.85% | 1.73% |
| 2023 | 19.51% | 57.72% |
| 2022 | 12.37% | 24.19% |
| 2021 | 9.96% | -20.82% |
| 2020 | 12.58% | -6.16% |
| 2019 | 13.41% | 72.89% |
| 2018 | 7.75% | -20.10% |
| 2017 | 9.71% | -37.76% |
Dr. Reddy's Laboratories Limited (RDY) Average ROE
How has RDY ROE performed in the past?
The current ROE of Dr. Reddy's Laboratories Limited (RDY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
16.06%
5-year avg
16.01%
10-year avg
13.35%
Dr. Reddy's Laboratories Limited (RDY) ROE vs. Peers
How is RDY’s ROE compared to its peers?
Dr. Reddy's Laboratories Limited’s ROE is greater than Elanco Animal Health Incorporated (-3.64%), greater than Viatris Inc. (-1.97%), less than Encompass Health Corporation (25.35%), less than Exelixis, Inc. (40.21%), less than Revvity, Inc. (3.28%), less than BioMarin Pharmaceutical Inc. (4.41%), greater than Revolution Medicines, Inc. (-83.22%), less than Solventum Corporation (30.71%), less than Neurocrine Biosciences, Inc. (21.64%), less than The Ensign Group, Inc. (16.63%),
| Company | ROE | Market cap |
|---|---|---|
| -3.64% | $12.07B | |
| -1.97% | $19.19B | |
| 25.35% | $10.07B | |
| 40.21% | $13.35B | |
| 3.28% | $11.12B | |
| 4.41% | $10.81B | |
| -83.22% | $32.71B | |
| 30.71% | $13.66B | |
| 21.64% | $16.06B | |
| 16.63% | $8.73B |
Build a custom stock screener for Dr. Reddy's Laboratories Limited (RDY) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Dr. Reddy's Laboratories Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Dr. Reddy's Laboratories Limited (RDY) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Dr. Reddy's Laboratories Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Dr. Reddy's Laboratories Limited's ROE?
How is the ROE calculated for Dr. Reddy's Laboratories Limited (RDY)?
What is the highest ROE for Dr. Reddy's Laboratories Limited (RDY)?
What is the 3-year average ROE for Dr. Reddy's Laboratories Limited (RDY)?
What is the 5-year average ROE for Dr. Reddy's Laboratories Limited (RDY)?
How does the current ROE for Dr. Reddy's Laboratories Limited (RDY) compare to its historical average?